Transcription factor MITF regulates cardiac growth and hypertrophy

Journal of Clinical Investigation

Volumn 116, Issue 10, 2006, Pages 2673-2681

  Tshori, Sagi ^a   Gilon, Dan ^b   Beeri, Ronen ^b   Nechushtan, Hovav ^b   Kaluzhny, Dmitry ^a   Pikarsky, Eli ^b   Razin, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ISOPRENALINE; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PAX3;

ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CONTROLLED STUDY; HEART DEVELOPMENT; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART OUTPUT; HEART STRESS; HEART WEIGHT; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BODY WEIGHT; CARDIOMEGALY; CELL ENLARGEMENT; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEART; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MODELS, BIOLOGICAL; MUTATION; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NIH 3T3 CELLS; ORGAN SIZE; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING;

EID: 33749451494     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27643     Document Type: Article

References (43)

1. Van Bilsen, M., and Chien, K.R. 1993. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc. Res. 27:1140-1149.
2. Saadane, N., Alpert, L., and Chalifour, L.E. 1999. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br. J. Pharmacol. 127:1165-1176.
3. Akazawa, H., and Komuro, I. 2003. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92:1079-1088.
4. Hemesath, T.J., Price, E.R., Takemoto, C., Badalian, T., and Fisher, D.E. 1998. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 391:298-301.
5. Dorsky, R.I., Raible, D.W., and Moon, R.T. 2000. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev. 14:158-162.
6. Takeda, K., et al. 2000. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum. Mol. Genet. 9:125-132.
7. Hodgkinson, C.A., et al. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 74:395-404.
8. Hughes, M.J., Lingrel, J.B., Krakowsky, J.M., and Anderson, K.P. 1993. A helix-loop-helix transcription factor-like gene is located at the mi locus. J. Biol. Chem. 268:20687-20690.
9. Moore, K.J. 1995. Insight into the microphthalmia gene. Trends Genet. 11:442-450.
10. Tassabehji, M., Newton, V.E., and Read, A.P. 1994. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8:251-255.
11. Steingrimsson, E., et al. 1994. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8:256-263.
12. Hemesath, T.J., et al. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8:2770-2780.
13. Ito, A., et al. 1999. Inhibitory effect of the transcription factor encoded by the mi mutant allele in cultured mast cells of mice. Blood. 93:1189-1196.
14. Bentley, N.J., Eisen, T., and Goding, C.R. 1994. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14:7996-8006.
15. Isozaki, K., et al. 1994. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype. Am. J. Pathol. 145:827-836.
16. Ito, A., et al. 1998. Systematic method to obtain novel genes that are regulated by mi transcription factor: impaired expression of granzyme B and tryptophan hydroxylase in mi/mi cultured mast cells. Blood. 91:3210-3221.
17. Morii, E., et al. 1996. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood. 88:2488-2494.
18. Nechushtan, H., Zhang, Z., and Razin, E. 1997. Microphthalmia (mi) in murine mast cells: regulation of its stimuli-mediated expression on the translational level. Blood. 89:2999-3008.
19. Sato, M., et al. 1999. Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localization. Biochem. Biophys. Res. Commun. 254:384-387.
20. Razin, E., et al. 1999. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J. Biol. Chem. 274:34272-34276.
21. Levy, C., Nechushtan, H., and Razin, E. 2002. A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277:1962-1966.
22. Weilbaecher, K.N., et al. 1998. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187:775-785.
23. Schafer, K., Neuhaus, P., Kruse, J., and Braun, T. 2003. The homeobox gene Lbx1 specifies a subpopulation of cardiac neural crest necessary for normal heart development. Circ. Res. 92:73-80.
24. Salathe, M. 2002. Effects of beta-agonists on airway epithelial cells. J. Allergy Clin. Immunol. 110:S275-S281.
25. Ji, M., and Andrisani, O.M. 2005. High-level activation of cyclic AMP signaling attenuates bone morphogenetic protein 2-induced sympathoadrenal lineage development and promotes melanogenesis in neural crest cultures. Mol. Cell. Biol. 25:5134-5145.
26. Gardner, D.G. 2003. Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol. Metab. 14:411-416.
27. Tamura, N., et al. 2000. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U. S. A. 97:4239-4244.
28. Ellmers, L.J., et al. 2002. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 283:H707-H714.
29. Nakagawa, Y., et al. 2006. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat. Med. 12:107-113.
30. Molina, D.M., Grewal, S., and Bardwell, L. 2005. Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation. J. Biol. Chem. 280:42051-42060.
31. Motyckova, G., et al. 2001. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. U. S. A. 98:5798-5803.
32. Steingrimsson, E., et al. 2002. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc. Natl. Acad. Sci. U. S. A. 99:4477-4482.
33. Troen, B.R. 2004. The role of cathepsin K in normal bone resorption. Drug News Perspect. 17:19-28.
34. Stypmann, J., et al. 2002. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc. Natl. Acad. Sci. U. S. A. 99:6234-6239.
35. Carreira, S., et al. 2005. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature. 433:764-769.
36. Du, J., et al. 2004. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell. 6:565-576.
37. Tamamori, M., et al. 1998. Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am. J. Physiol. 275:H2036-H2040.
38. Sadoshima, J., Aoki, H., and Izumo, S. 1997. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ. Res. 80:228-241.
39. Lupu, F., Terwilliger, J.D., Lee, K., Segre, G.V., and Efstratiadis, A. 2001. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 229:141-162.
40. Hallaq, H., Hasin, Y., Fixler, R., and Eilam, Y. 1989. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes. J. Pharmacol. Exp. Ther. 248:716-721.
41. Mori, T., et al. 2004. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc. Res. 61:771-779.
42. Gropp, M., et al. 2003. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol. Ther. 7:281-287.
43. Schiller, N.B., et al. 1989. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2:358-367.